What is Kratom?

It is a plant that contains over 40 alkaloid and non-alkaloid compounds, some of which have analgesic and psychoactive properties.


Kratom is a plant known scientifically as Mitragynia speciosa. It is a species of tree that grows in Southeast Asia and Africa.1 People who live in these areas use kratom in traditional medicine and spiritual practices. Also, at low doses, kratom is a stimulant. Many people use it to increase their endurance while working. In certain countries like Thailand, kratom use is considered a way of life that is embedded in local customs and traditions.2

There are over 40 compounds in kratom leaves.1 Some are biologically active, some are not, and the activity of dozens of them is unknown. Some of the major compounds in kratom are mitragynine (the primary compound), 7- hydroxymitragynine (7-OH), and paynantheine (Figure 1).1,3

Figure 1: The chemical structure of some of the active compounds found in kratom.

Hooper was the first to isolate mitragynine in 1907.4  Its crystal structure was determined 1965.5

A 2013 review article says that mitragynine comprises about 66% of the alkaloids in kratom extract.6 Mitragynine is followed by paynantheine (9%), speciogynine (7%), and 7-OH (2%). More than a dozen other alkaloid compounds are present at <1%.

Several studies have examined the metabolic fate of mitragynine in rats and humans.7–12 Using this previous work, Philipp et al. proposed metabolic pathways for the breakdown of mitragynine in rats and humans in 2011.1

The Effects of Some Compounds in Kratom

Studies have shown that the analgesic effects of kratom depend on the route of administration. The potency of mitragynine was similar to codeine in several species when it was administered orally or interperitoneally.14 However, it did not have an analgesic effect in rats and mice when given subcutaneously.

To explain this phenomenon, the authors of the study suggested that mitragynine was converted to an active metabolite during first-pass metabolism after being given orally or intraperitoneally. Thus, perhaps the analgesic effects were due to a metabolite of mitragynine and not mitragynine itself. However, another study found that mitragynine elicited its analgesic effects when administered directly into the cerebrospinal fluid in the brain, which would eliminate most of the effects (if any) of first-pass metabolism.15

At higher doses, kratom extracts can as an analgesic.3 It is also used to treat opium withdrawal symptoms including in self-treatment.16 Kratom is also used for relieving fever, diarrhea, depression, and anxiety.17–21 In addition, kratom extracts are known to have antimicrobial, antioxidant,22 and anti-inflammatory23 properties.

Studies show that raw kratom extract has analgesic effects in rodents.23–27 Also, these studies indicate that mitragynine by itself has analgesic effects in several species.

Studies indicate that 7-OH also has analgesic effects. This activity may happen via hMOR. Moreover, researchers have found that 7-OH is more potent at hMOR than morphine.15,28

The Receptors Involved in Eliciting the Effects of Kratom

The opioid receptors are the primary target of mitragynine and other compounds found in kratom extracts. Mitragynine also binds to several other receptor types, including dopamine D2, 5-HT2C, and 5-HT7.16

Both mitragynine and 7-OH are partial agonists at the human mu-opioid receptor (hMOR).29,30 The data indicate that 7-OH has greater potency than mitragynine. Also, the binding affinities (Ki) of mitragynine and 7-OH at hMOR are 233 nM and 47 nM, respectively.

Mitragynine and 7-OH act as competitive antagonists at the human kappa (hKOR) and delta (hDOR) receptors. However, studies show that their antagonist activity at hDOR is weak.29

More Research is Needed on Kratom and Its Constituents

It is unclear at this time how much if any, the serotonin 5-HT2A receptor (the one that is activated by the classic psychedelics) is involved in the effects of kratom compounds. It is likely that the combination of effects from several different types of receptors results in the overall effects that the user experiences from kratom.

Barb Bauer Headshot

Barb is the former Editor and one of the founders of Psychedelic Science Review. She is currently a contributing writer. Her goal is making accurate and concise psychedelic science research assessable so that researchers and private citizens can make informed decisions.


Notify of

1 Comment
Newest Most Voted
Inline Feedbacks
View all comments
Anna Isabel
3 years ago

Thanks for sharing this type blog.this blog is very informative and effective.I am really like your blog too much.

  1. Tohar N. Volatile compounds and alkaloids from the aqueous extract of Mitragyna speciosa and their in vitro and in vivo anti-inflammatory studies. Doctoral thesis. University of Malaya, Kuala Lumpur. 2016. https://pdfs.semanticscholar.org/6279/b3f059c3225e71b6f0bb36cb1fa3ff0bc810.pdf.
  2. Tanguay P. Kratom in Thailand: Decriminalisation and Community Control? Transnational Institute Series on Legislative Reform of Drug Policies. 2100;(13).
  3. Kruegel AC, Grundmann O. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology. 2018;134:108-120. doi:10.1016/j.neuropharm.2017.08.026
  4. Hooper D. The anti-opium leaf. Pharmaceutical Journal. 1907;78:453.
  5. Zacharias DE, Rosenstein RD, Jeffrey GA. The structure of mitragynine hydroiodide. Acta Cryst. 1965;18(6):1039-1043. doi:10.1107/S0365110X65002499
  6. Hassan Z, Muzaimi M, Navaratnam V, et al. From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews. 2013;37(2):138-151. doi:10.1016/j.neubiorev.2012.11.012
  7. Kaewklum D, Kaewklum M, Pootrakronchai R, Tassana U, Wilairat P, Anukarahanonta T. Detection of mitragynine and its metabolite in urine folliwng ingestion of leaves of Mitragyna speciosa korth. In: Schanzer W, Geyer H, Gotzmann A, Mareck U, eds. Recent Advances in Doping Analysis. Köln: Sport und Buch Strauß; 2005:403-406.
  8. Philipp AA, Wissenbach DK, Zoerntlein SW, Klein ON, Kanogsunthornrat J, Maurer HH. Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry. Journal of Mass Spectrometry. 2009;44(8):1249-1261. doi:10.1002/jms.1607
  9. Lu S, Tran BN, Nelsen JL, Aldous KM. Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 2009;877(24):2499-2505. doi:10.1016/j.jchromb.2009.06.024
  10. Maurer HH. Chemistry, Pharmacology, and Metabolism of Emerging Drugs of Abuse. Therapeutic Drug Monitoring. 2010;32(5):544–549. doi:10.1097/FTD.0b013e3181eea318
  11. Arndt T, Claussen U, Güssregen B, et al. Kratom alkaloids and O-desmethyltramadol in urine of a “Krypton” herbal mixture consumer. Forensic Science International. 2011;208(1):47-52. doi:10.1016/j.forsciint.2010.10.025
  12. Le D, Goggin MM, Janis GC. Analysis of Mitragynine and Metabolites in Human Urine for Detecting the Use of the Psychoactive Plant Kratom. J Anal Toxicol. 2012;36(9):616-625. doi:10.1093/jat/bks073
  13. Philipp AA, Wissenbach DK, Weber AA, Zapp J, Maurer HH. Metabolism studies of the Kratom alkaloids mitraciliatine and isopaynantheine, diastereomers of the main alkaloids mitragynine and paynantheine, in rat and human urine using liquid chromatography–linear ion trap-mass spectrometry. Journal of Chromatography B. 2011;879(15):1049-1055. doi:10.1016/j.jchromb.2011.03.005
  14. Macko E, Weisbach JA, Douglas B. Some observations on the pharmacology of mitragynine. Arch Int Pharmacodyn Ther. 1972;198(1):145-161.
  15. Matsumoto K, Horie S, Ishikawa H, et al. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sciences. 2004;74(17):2143-2155. doi:10.1016/j.lfs.2003.09.054
  16. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008;103(6):1048-1050. doi:10.1111/j.1360-0443.2008.02209.x
  17. Adkins J, Boyer E, McCurdy C. Mitragyna speciosa, A Psychoactive Tree from Southeast Asia with Opioid Activity. Current Topics in Medicinal Chemistry. 2011;11(9). doi:info:doi/10.2174/156802611795371305
  18. Matsumoto K. Pharmacological Studies on 7-Hydroxymitragynine, Isolated from the Thai Herbal Medicine Mitragyna speciosa: Discovery of an Orally Active Opioid Analgesic. Doctoral Thesis. Chiba University, Chiba, Japan. 2006.
  19. Raffa RB, Beckett JR, Brahmbhatt VN, et al. Orally Active Opioid Compounds from a Non-Poppy Source. Journal of Medicinal Chemistry. 2013;56(12):4840-4848. doi:10.1021/jm400143z
  20. Takayama H. Chemistry and Pharmacology of Analgesic Indole Alkaloids from the Rubiaceous Plant, Mitragyna speciosa. Chem Pharm Bull. 2004;52(8):916-928.
  21. Takayama H, Ishikawa H, Kurihara M, et al. Studies on the Synthesis and Opioid Agonistic Activities of Mitragynine-Related Indole Alkaloids: Discovery of Opioid Agonists Structurally Different from Other Opioid Ligands. Journal of Medicinal Chemistry. 2002;45(9):1949-1956. doi:10.1021/jm010576e
  22. Parthasarathy S, Bin Azizi J, Ramanathan S, et al. Evaluation of Antioxidant and Antibacterial Activities of Aqueous, Methanolic and Alkaloid Extracts from Mitragyna Speciosa (Rubiaceae Family) Leaves. Molecules. 2009;14(10):3964-3974. doi:10.3390/molecules14103964
  23. Shaik Mossadeq WM, Sulaiman MR, Tengku Mohamad TA, et al. Anti-Inflammatory and Antinociceptive Effects of Mitragyna speciosa Korth Methanolic Extract. Medical Principles and Practice. 2009;18(5):378-384. doi:10.1159/000226292
  24. Carpenter JM, Criddle CA, Craig HK, et al. Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats. Fitoterapia. 2016;109:87-90. doi:10.1016/j.fitote.2015.12.001
  25. Reanmongkol W, Keawpradub N, Sawangjaroen K. Effects of the extracts from Mitragyna speciosa Korth. leaves on analgesic and behavioral activities in experimental animals. J Sci Technol. 2007;29(1):39-48.
  26. Sabetghadam A, Ramanathan S, Mansor SM. The evaluation of antinociceptive activity of alkaloid, methanolic, and aqueous extracts of Malaysian Mitragyna speciosa Korth leaves in rats. Pharmacognosy Res. 2010;2(3):181-185. doi:10.4103/0974-8490.65514
  27. Sabetghadam A, Navaratnam V, Mansor SM. Dose-Response Relationship, Acute Toxicity, and Therapeutic Index between the Alkaloid Extract of Mitragyna speciosa and Its Main Active Compound Mitragynine in Mice: Mitragynine Efficacy and Safety. Drug Development Research. 2013;74(1):23-30. doi:10.1002/ddr.21052
  28. Ponglux D, Wongseripipatana S, Takayama H, et al. A new indole alkaloid, 7α-hydroxy-7H-mitragynine from Mitragyna speciosa in Thailand. Planta Medica. 1994;60:580-581.
  29. Kruegel AC, Gassaway MM, Kapoor A, et al. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators. J Am Chem Soc. 2016;138(21):6754-6764. doi:10.1021/jacs.6b00360
  30. Yamamoto LT, Horie S, Takayama H, et al. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa. General Pharmacology: The Vascular System. 1999;33(1):73-81. doi:10.1016/S0306-3623(98)00265-1